Načítá se...
Suboptimal response to COVID-19 mRNA vaccines in hematologic malignancies patients
Studies describing SARS-CoV-2 immune responses following mRNA vaccination in hematology malignancy (HM) patients are virtually non-existent. We measured SARS-CoV-2 IgG production in 67 HM patients who received 2 mRNA vaccine doses. We found that 46% of HM patients did not produce antibodies and were...
Uloženo v:
| Vydáno v: | medRxiv |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Cold Spring Harbor Laboratory
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8043479/ https://ncbi.nlm.nih.gov/pubmed/33851182 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2021.04.06.21254949 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|